Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Cornberg

Showing results (161-170 of 350) with videos related to

Pageof 35
Sort By:
Frontiers in Immunology|January 7, 2014
Clonal exhaustion as a mechanism to protect against severe immunopathology and death from an overwhelming CD8 T cell responseMarkus Cornberg, Laurie L Kenney, Alex T Chen, et al.
European Journal of Gastroenterology & Hepatology|April 30, 2020
Utilization and effectiveness of elbasvir/grazoprevir and adoption of resistance-associated substitutions testing in real-world treatment of hepatitis C virus genotype 1A infection: results from the German Hepatitis C-RegistryHolger Hinrichsen, Albrecht Stoehr, Markus Cornberg, et al.
Viral Immunology|November 8, 2012
Improved immune status corresponds with long-term decline of quantitative serum hepatitis B surface antigen in HBV/HIV co-infected patientsEduard Arendt, Jerzy Jaroszewicz, Jürgen Rockstroh, et al.
Journal of Viral Hepatitis|December 15, 2018
Role of soluble inflammatory mediators and different immune cell populations in early control of symptomatic acute hepatitis C virus infectionJulia Hengst, Andreas L Klein, Sebastian Lunemann, et al.
Zeitschrift Fur Gastroenterologie|November 30, 2017
Interferon-free cure of chronic Hepatitis C is associated with weight gain during long-term follow-upBernhard Schlevogt, Katja Deterding, Kerstin Port, et al.
European Journal of Gastroenterology & Hepatology|July 3, 2014
Limited effectiveness and safety profile of protease inhibitor-based triple therapy against chronic hepatitis C in a real-world cohort with a high proportion of advanced liver diseaseBenjamin Maasoumy, Kerstin Port, Katja Deterding, et al.
Journal of Hepatology|May 15, 2018
Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis BFranziska Rinker, Christine L Zimmer, Christoph Höner Zu Siederdissen, et al.
Antiviral Therapy|June 27, 2007
Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis CJohannes Wiegand, Markus Cornberg, Nuray Aslan, et al.
Hepatology Communications|September 25, 2021
HBcrAg Levels Are Associated With Virological Response to Treatment With Interferon in Patients With Hepatitis DeltaLisa Sandmann, Cihan Yurdaydin, Katja Deterding, et al.
European Journal of Immunology|July 29, 2023
Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct-acting antiviralsWenjie Bi, Anke Kraft, Sophie Engelskircher, et al.
Pageof 35

Showing results (161-170 of 350) with videos related to

Sort By:
Pageof 35
Frontiers in Immunology|January 7, 2014
Clonal exhaustion as a mechanism to protect against severe immunopathology and death from an overwhelming CD8 T cell responseMarkus Cornberg, Laurie L Kenney, Alex T Chen, et al.
European Journal of Gastroenterology & Hepatology|April 30, 2020
Utilization and effectiveness of elbasvir/grazoprevir and adoption of resistance-associated substitutions testing in real-world treatment of hepatitis C virus genotype 1A infection: results from the German Hepatitis C-RegistryHolger Hinrichsen, Albrecht Stoehr, Markus Cornberg, et al.
Viral Immunology|November 8, 2012
Improved immune status corresponds with long-term decline of quantitative serum hepatitis B surface antigen in HBV/HIV co-infected patientsEduard Arendt, Jerzy Jaroszewicz, Jürgen Rockstroh, et al.
Journal of Viral Hepatitis|December 15, 2018
Role of soluble inflammatory mediators and different immune cell populations in early control of symptomatic acute hepatitis C virus infectionJulia Hengst, Andreas L Klein, Sebastian Lunemann, et al.
Zeitschrift Fur Gastroenterologie|November 30, 2017
Interferon-free cure of chronic Hepatitis C is associated with weight gain during long-term follow-upBernhard Schlevogt, Katja Deterding, Kerstin Port, et al.
European Journal of Gastroenterology & Hepatology|July 3, 2014
Limited effectiveness and safety profile of protease inhibitor-based triple therapy against chronic hepatitis C in a real-world cohort with a high proportion of advanced liver diseaseBenjamin Maasoumy, Kerstin Port, Katja Deterding, et al.
Journal of Hepatology|May 15, 2018
Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis BFranziska Rinker, Christine L Zimmer, Christoph Höner Zu Siederdissen, et al.
Antiviral Therapy|June 27, 2007
Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis CJohannes Wiegand, Markus Cornberg, Nuray Aslan, et al.
Hepatology Communications|September 25, 2021
HBcrAg Levels Are Associated With Virological Response to Treatment With Interferon in Patients With Hepatitis DeltaLisa Sandmann, Cihan Yurdaydin, Katja Deterding, et al.
European Journal of Immunology|July 29, 2023
Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct-acting antiviralsWenjie Bi, Anke Kraft, Sophie Engelskircher, et al.
Pageof 35